ARIAD Pharmaceuticals Competitors and Similar CompaniesClear all

ARIAD Pharmaceuticals's competitors and similar companies include GlycoMimetics, Processa Pharmaceuticals and Providence Therapeutics.

	ARIAD Pharmaceuticals ARIAD Pharmaceuticals is a global oncology company focused on discovering, developing and commercializing precision therapies for patients with rare cancers.	GlycoMimetics GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.	Processa Pharmaceuticals Processa Pharmaceuticals (formerly Heatwurx) is a company focused on developing treatments for patients with an unmet medical need.	Providence Therapeutics Providence Therapeutics is a company that develops personalized mRNA-based cancer vaccines.
Founding Date	Founding Date 1991	Founding Date 2003	Founding Date 2017	Founding Date 2015
Type	Type Subsidiary	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Cambridge, US HQ Boston, US Chicago, US Cincinnati, US Dallas, US Minneapolis, US New York, US see more	Locations Rockville, US HQ	Locations Hanover, US HQ	Locations Calgary, CA HQ
Employees	Employees 1381% increase	Employees 5025% increase	Employees 1033% decrease	Employees 5610% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 31.6 m	Valuation ($) 4.4 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $118.8m (FY, 2015)	Revenue (est.) $10.8m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Net income	Net income ($231.2m) (FY, 2015)	Net income ($153.9m) (FY, 2025)	Net income ($13.6m) (FY, 2025)	Net income N/A